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Several studies indicate that organ failure is the leading cause
of death in surgical patients [1]. Most cases of multiple organ
dysfunction are precipitated by infection. Nonetheless, the
outcome of organ dysfunction does not correlate well with the
microbiology of multiple organ dysfunction syndrome [2].
Several studies indicate that a causal relationship exists
between the surgical or traumatic injury and the predisposition
of these patients to develop septic/infectious complications
and/or multiple organ failure [3–5]. The excessive inflammatory
response, together with a dramatic paralysis of cell-mediated
immunity following major surgery [3,6], appears to be responsi-
ble for the increased susceptibility to subsequent sepsis.
In view of this, most of the scientific and medical research
has been directed towards measuring the progression and
inter-relationship of mediators that are activated or sup-
pressed following major surgery. In most clinical studies alter-
ations in immune parameters of patients following surgery
have been assessed due to evaluation of peripheral blood cell
function and plasma levels of various mediators. Therefore,
animal models have been utilized that simulate the clinical
conditions. This has allowed us to better define the patho-
physiology of the immunoinflammatory response following
surgical trauma, which reduces the patient’s capability to
resist subsequent life-threatening infectious complications.
This article will focus on the effect of blood loss and surgical
injury on cell-mediated immune responses in experimental
studies utilizing models of trauma and hemorrhagic shock,
which have defined effects on the immunoinflammatory
response. Subsequently each paragraph will discuss how the
findings from these experimental studies correlate with data
generated from surgical patients. The effect of surgeries on
the susceptibility to polymicrobial sepsis and infection will then
be illustrated. These studies may generate new approaches
for the treatment of immunodepression following major
surgery, thus reducing the susceptibility to infection and
increasing the survival rate of the critical ill surgical patient.
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Abstract
Several studies indicate that organ failure is the leading cause of death in surgical patients. An
excessive inflammatory response followed by a dramatic paralysis of cell-mediated immunity following
major surgery appears to be responsible for the increased susceptibility to subsequent sepsis. In view
of this, most of the scientific and medical research has been directed towards measuring the
progression and inter-relationship of mediators following major surgery. Furthermore, the effect of
those mediators on cell-mediated immune responses has been studied. This article will focus on the
effect of blood loss and surgical injury on cell-mediated immune responses in experimental studies
utilizing models of trauma and hemorrhagic shock, which have defined effects on the
immunoinflammatory response. Subsequently these findings will be correlated with data generated
from surgical patients. The results of these studies may generate new approaches for the treatment of
immunodepression following major surgery, thus reducing the susceptibility to infection and increasing
the survival rate of the critical ill surgical patient.
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Macrophage function following surgery
Macrophage cytokine release
Altered host defense mechanisms after major surgery or
trauma are considered important for the development of
infectious complications and sepsis. Immune deterioration
has also been reported in patients after trauma and surgery.
In this respect, studies have shown areactivity of circulating
monocytes towards stimulation with bacteria or endotoxin fol-
lowing surgical trauma [7]. This paralysis of monocyte cell
function has been reported to persist for three to five days
after trauma [8] and appears to be a potential risk factor for
postoperative septic complications [7].
In contrast, other studies demonstrate an enhanced secretion
of IL-1β and IL-10 by endotoxin-stimulated peripheral blood
monocytes at different time points after surgery [9]. Differ-
ences in the severity of the surgical trauma might account for
those divergent results.
In addition to cytokine release patterns, a high acute physiol-
ogy and chronic health evaluation (APACHE) II score was
associated with an increased number of proinflammatory
CD14+ CD16+ monocytes [10]. Furthermore, high levels of
CD14+ CD16+ monocytes remained in patients with persis-
tently high APACHE II scores [10].
Macrophage antigen presentation following major
surgery
Antigen presentation is defined as a process whereby a cell
expresses antigen on its surface in a form capable of being
recognized by a T cell. The proteinaceous antigen typically
undergoes some form of processing in which it is degraded
into small peptides that are capable of associating with MHC
class II antigen for presentation to helper T lymphocytes or in
association with MHC class I antigen to become a target for
cytotoxic T lymphocytes [11]. However, for competent antigen
presentation to take place, the antigen-presenting
macrophage must provide a second costimulatory signal, in
the form of a membrane and/or soluble factor. Impaired mono-
cyte function and disruption of monocyte/T cell interaction
have been shown to be crucial for the development of septic
complications in surgical patients [12]. It this respect, human
leukocyte antigen (HLA-DR) receptor expression is depressed
in some surgical patients and correlates with sepsis severity
and outcome [12]. Furthermore, a significant shift toward Fc
receptor monocyte subsets can be found. This subpopulation
resembles activated macrophages characterized by high
proinflammatory cytokine synthesis and suppressed antigen
presentation. Similarly, Wakefield et al. demonstrated that an
earlier recovery of the depressed HLA-DR expression was
associated with a lower rate of septic complications [13].
It should be noted that a normal or enhanced capacity of
peripheral blood monocytes to present bacterial superanti-
gens and to stimulate T cell proliferation after surgery has
been found despite decreased HLA-DR antigen presentation
[9]. These changes were evident despite a significant loss of
cell surface HLA-DR molecules. Thus, the level of MHC class
II protein expression does not necessarily predict the antigen-
presenting capacity of monocytes obtained from surgical
patients with uneventful postoperative recovery [9].
Moreover, MacLean et al. [14] and Christou et al. [15] have
reported that the outcome of trauma patients is worsened
when they exhibit a depressed, delayed-type hypersensitivity
reaction (which is antigen specific). Thus, depressed cell-
mediated immunity in patients following injury or major
surgery, which is associated with an increased mortality from
subsequent sepsis [16,17] is probably due, in part, to
decreased antigen-presenting capacity by macrophages.
These above findings collectively suggest that the depression
of macrophage antigen presentation capacity following injury
or major surgery is an important contributory factor to the
depression of cell-mediated immunity, thereby, increasing
subsequent susceptibility to infection. Interestingly, multiple
factors (which include decreased metabolic activity, anti-
inflammatory cytokines, prostaglandins and nitric oxide)
appear to be responsible for the depression of macrophage
antigen-presenting capacity.
These changes in macrophage function appear to be irre-
versible. Therefore, we treated patients undergoing major
surgery with 15 µg granulocyte colony stimulating factor
(G-CSF) perioperatively, which reduced the acute inflamma-
tory response. This anti-inflammatory effect of G-CSF might
contribute to the normalization of the depressed lipopolysac-
charide-induced cytokine release by monocytes following
major surgery. Moreover, administration of G-CSF normalized
the depressed HLA-DR expression in surgical patients. It is
our hypothesis, that G-CSF induces the release of new, unal-
tered monocytes postoperatively, thereby preventing immuno-
suppression. Whether these effects of G-CSF result in a
decreased infection rate following major surgery remains to
be determined in a larger clinical trial.
Lymphocyte function following hemorrhagic
shock
Both experimental and clinical studies indicate that a wide
range of traumatic injuries alter the ability of T lymphocytes to
respond to mitogenic activation (by concanavalin A and phy-
tohemagglutinin) [18–23]. These studies demonstrate
decreased mitogenic response of lymphocytes in patients fol-
lowing general surgery, blunt trauma, and thermal injury
[20–24]. Interestingly the degree of lymphocyte depression
correlated with the complexity of the surgery. Similarly, follow-
ing trauma-hemorrhage decreased splenocyte proliferative
capacity in response to the T cell mitogen, concanavalin A,
has been demonstrated extensively in our laboratory
[18,19,25,26]. In addition, Hensler et al. showed a severe
defect of T lymphocyte proliferation and cytokine secretion in
vitro following major surgery. In these studies, reducedCritical Care    August 2002 Vol 6 No 4 Angele and Faist
cytokine secretion by T lymphocytes was observed for IL-2,
IFN-γ, and tumor necrosis factor α (TNF-α) during the early
postoperative course [9]. Monocyte functions, however, were
not altered, suggesting a predominant defect in the T cell
response rather than an impaired monocyte antigen-present-
ing capacity. Thus, suppression of T-cell effector functions
during the early phase of the postoperative course may define
a state of impaired defense against pathogens and increased
susceptibility to infection and septic complications.
Similarly, the release of Th1 lymphokines (i.e. IL-2, IFN-γ) by
splenocytes has been shown to be significantly depressed as
early as two hours following experimental trauma and hemor-
rhagic shock, simulating surgical trauma [18,19,25,26] and
this depression persists for up to five days following trauma-
hemorrhage [26]. In contrast to Th1 lymphokines, the release
of the anti-inflammatory Th2 lymphokine, IL-10, has been
shown to be increased after trauma-hemorrhage in mice [18].
Neutralizing IL-10 by the addition of anti-IL-10 monoclonal
antibodies to the culture media restored the depressed
splenocyte proliferative capacity in splenocytes harvested
from traumatized animals [18]. Moreover, early anti-IL-10 treat-
ment following burn injury prevented T cell immunosuppres-
sion and improved the survival rate following subsequent
sepsis [27]. Thus, IL-10 following trauma-hemorrhage might
contribute to the depressed splenocyte Th1 lymphokine
release following trauma and injury. In contrast, van der Poll et
al. demonstrated in a model of endotoxemia an increased mor-
tality rate following anti-IL-10 treatment, suggesting protective
effects of IL-10 following lipopolysaccharide injection [28].
Depending on the model and the time of administration, anti-
IL-10 might exhibit divergent effects on immune responses.
In addition to release patterns, T lymphocyte subsets have
been determined in patients with acute illness [29]. These
studies indicate that following major surgery, both cell popu-
lations decrease. Patients that develop septic complications,
however, display a predominant decrease in CD4+cells [30].
Moreover, changes in B cell function have also been reported
following surgical trauma. The capacity of splenic B cells to
produce antibodies is significantly decreased following trauma
and blood loss [31,32]. In this regard, a decrease in overall
serum levels of immunoglobulin was seen for up to three days
after surgical trauma and blood loss [31,32]. The decreased
IL-2 production by T lymphocytes has been suggested to be
responsible for the downregulation of antibody production by
B cells following severe injury, since T cell lymphokines are a
prerequisite for adequate B cell proliferation and immunoglob-
ulin secretion [3]. Whether restoration of T cell function follow-
ing severe injury and major surgery, however, restores the
depressed B cell function remains to be determined.
Circulatory inflammatory mediators
The observed immunodeficiency in trauma victims and
patients following major surgery has been found to be associ-
ated with enhanced concentrations of inflammatory cytokines,
reflecting activated immunocompetent cells in the patient
[33]. Thus, it appears that the depressed cell-mediated
immune responses in vitro discussed in the above para-
graphs reflect hyporesponsiveness to a second stimulus fol-
lowing massive activation in vivo [34].
In this respect, elevated levels of TNF-α, IL-1 and IL-6 in the
plasma have been well described in both animal experiments
[3,35,36] and patient studies [5,37–40] following trauma,
severe blood loss, and sepsis. The sequence of cytokine
release following trauma and hemorrhagic shock includes an
increase of plasma TNF-α as early as 30 min after the onset
of injury, peak TNF-α levels by two hours post trauma and
hemorrhage, and a return towards baseline values at
24 hours [3,35] (Fig. 1). In contrast to measurements using a
bioassay [35], elevated plasma TNF-α levels were detectable
at 24 hours post trauma and blood loss with the ELISA
(enzyme-linked immunosorbent assay) technique [41]. This
suggests that TNF-α detected 24 hours after injury might not
be biologically active. In this regard, soluble TNF-α receptors
that might neutralize the biological activity of circulating
TNF-α have been isolated from the plasma [42]. Unlike
TNF-α, plasma IL-6 levels are not significantly elevated until
two hours post hemorrhage, and the levels remain elevated
up to 24 hours after the induction of hemorrhage [43].
Since in vivo administration of IL-1, IL-6, and TNF-α [44–47]
induces a shock-like syndrome, similar to that observed fol-
lowing severe blood loss and sepsis, it has been suggested
that these cytokines may play a role in initiating the cascade
of events that can lead to the development of multiple organ
dysfunction following severe hemorrhagic shock.
Furthermore, the marked increase in the release of proinflamma-
tory cytokines by Kupffer cells following trauma and blood loss
in experimental studies has been reported to be associated with
depressed immune functions [3]. This suggests that proinflam-
matory cytokines produced by Kupffer cells following hemor-
rhage act in an autocrine as well as a paracrine fashion to
downregulate Kupffer cell and other macrophage populations.
Furthermore, Kupffer cells, which represent the largest pool of
macrophages in the body, were found to release increased
amounts of IL-1, IL-6, and TNF-α following shock [44] and the
selective reduction of this macrophage population by injection
of gadolinium chloride significantly reduced plasma IL-6 levels
following hemorrhage [48]. This leads to the conclusion that
Kupffer cells are a significant source of the increased plasma
levels of proinflammatory cytokines following trauma and hemor-
rhage, and these cytokines can act to depress macrophage
function. Whether or not Kupffer cells are the only contributors
to the enhanced proinflammatory plasma levels following severe
injury and major surgery remains to be determined.
In contrast to the early increase of proinflammatory cytokines
in the plasma following trauma and shock, elevated plasmalevels of the anti-inflammatory cytokine, transforming growth
factor (TGF)-β, are not detectable until 24 hours after the
insult [49]. Furthermore, this elevation in plasma TGF-β per-
sisted until 72 hours after trauma and hemorrhage [49]. Neu-
tralization of TGF-β antibodies restored the depressed
antigen presentation to normal levels [49]. These results,
along with the studies by Miller-Graziano et al. [50] indicate
that the enhanced release of TGF-β is an additional factor
responsible for the prolonged suppression of macrophage
function following hemorrhagic shock.
In addition to pro- and anti-inflammatory cytokines, numerous
other mediators in the plasma have been reported to con-
tribute to the depression of cell-mediated immune response
following trauma and shock. In this respect, eicosanoids have
been extensively studied as agents involved in immunological
responses [51–53]. Two hours after shock, an increased
release of prostaglandins and leukotrienes by macrophages
occurs leading to elevated plasma levels of eicosanoids
[3,54]. Moreover, prostaglandin E2 has been shown to inhibit
cell-mediated immune function [55,56]. Conversely, adminis-
tration of ibuprofen (an inhibitor of cyclooxygenase) to animals
following severe blood loss prevented the depression of
macrophage functions [57]. Ayala et al. [58] have also demon-
strated that rodents that were pre-fed a fish oil diet high in
omega-3-fatty acids (known to inhibit the synthesis of
prostaglandin E2 via inhibition of arachidonic acid metabolism)
had normal macrophage functions following hemorrhage.
Increased levels of circulating cytokines have also been
reported following a variety of tissue insults in patients,
including trauma, sepsis, thermal injury, and surgery
[5,40,59,60]. In this regard, increased plasma IL-6 levels in
patients have been observed during the first week following
trauma [40]. Interestingly, levels of proinflammatory cytokines
have been shown to be higher in trauma patients with severe
blood loss compared to patients with trauma alone [5]. More-
over, in septic patients the increase of the proinflammatory
cytokines IL-6 and TNF-α has been found to be much higher
than in trauma victims without septic complications [40].
These findings suggest additive effects of trauma, blood loss,
and septic complications on the immunoinflammatory
response. Furthermore, proinflammatory cytokine levels, as
well as the duration of elevation, appear to correlate with the
severity of the insult. In addition, elevated cytokine levels have
been shown to persist for five days after gastrectomy, com-
pared to three days after mastectomy [60]. Furthermore,
several clinical studies have shown an association between
elevated plasma levels of proinflammatory cytokines,
increased infectious complications, and higher mortality rates
[5,37,61–65]. In this respect, Molloy et al. reported a pro-
gressive decline in TNF-α levels in survivors of septic shock,
whereas TNF-α levels remained persistently elevated after
initial diagnosis and attempted treatment in nonsurvivors from
septic shock [66].
The above studies suggest the important contribution of
proinflammatory cytokines to the pathophysiological changes
seen in surgical patients and trauma victims. Therefore, deter-
mination of proinflammatory cytokine levels might become
important for clinicians who encounter a trauma patient in the
intensive care unit. Knowledge of the patient’s cytokine levels
may give him/her some indicator of the intracellular milieu,
and possibly insight into cellular changes taking place. This
information might give the clinician a better understanding of
how to treat such a critically ill trauma patient. More refine-
ments towards the rapid and online measurements of
cytokines are needed, however, before the full benefits of
such information can be effectively translated to better man-
agement of trauma patients. Although various cytokine thera-
pies in septic patients so far have not yielded satisfactory
results, the lack of beneficial effects might be related to the
timing and dose of anti-cytokine administration. It is our
hypothesis that total blockade/neutralization of cytokines will
not be helpful to the host. Instead, modulation of cytokine
production/release by immune cells (i.e. macrophages, T
cells) leading to the restoration of cellular homeostasis might
be a better approach for decreasing the susceptibility of
trauma victims and patients following major surgery to subse-
quent sepsis and infection.
Increased susceptibility to infection
The studies mentioned above indicate depressed immunore-
sponsiveness after trauma and hemorrhage, which persists
despite fluid resuscitation. To determine whether these
observations translate into an actual reduction in the capacity
of these traumatized animals to ward off infection of a clini-
cally relevant nature, additional studies were conducted by
Stephan et al. in which sepsis was induced 3 days after hem-
orrhagic shock [19]. The results demonstrate an increased
susceptibility of hemorrhaged animals to polymicrobial
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Figure 1
Arbitrary blood cytokine levels during the first 24 hours following
trauma and hemorrhagic shock. Levels of tumor necrosis factor α
(TNF-α), IL-6, and transforming growth factor β (TGF-β) were
determined by specific bioassay. IL-10 was measured by ELISA and
corticosterone was measured by radioimmunoassay.sepsis, as evidenced by an increased mortality rate of hemor-
rhaged animals following subsequent sepsis (mortality of
hemorrhaged animals following subsequent sepsis 100%
compared to 50% in sham animals subjected to sepsis)
[19,67]. Similarly, Zapata-Sirvent et al. have indicated that the
mortality rate in response to a septic challenge was increased
in mice [68]. Interestingly, restoration of the depressed
immune responses following trauma and severe blood loss
with immunomodulatory agents, such as flutamide (an andro-
gen receptor blocker), was associated with increased survival
rates following subsequent sepsis [67].
An association between the loss of immunocompetence
(paralysis of the cell-mediated immunity) in patients following
traumatic injury, and the development of sepsis and late
death has been reported [16,17] (Fig. 2). Furthermore, alter-
ations in the levels of circulating E-selectin adhesion mole-
cules after trauma and resuscitation have been found to be
associated with an increased risk for infections complica-
tions, organ failure, and death [69]. In summary, these studies
suggest that the immunodepression following injury and
major surgery leads to an increased susceptibility to polymi-
crobial sepsis. Therefore, attempts to modulate the
depressed immune responses in trauma victims might
decrease the development of septic complications and multi-
ple organ failure in those patients.
Gender-specific immune responses following
trauma, injury, and blood loss
Despite the fact that gender differences in the susceptibility
to, and morbidity from, sepsis have been observed in several
clinical and epidemiological studies [70–73], little attention
has been paid to gender when studying immune responses in
surgical and trauma patients. Furthermore, experimental
studies investigating alterations in immune functions following
trauma have used predominantly male laboratory animals.
Recent studies initiated by Zellweger et al. [74], however,
examined immune functions in female rodents following the
induction of sepsis by cecal ligation and puncture. The results
demonstrated maintenance of splenocyte function in females
when they were in the proestrus stage of the estrus cycle, as
opposed to depression of splenocyte function in males fol-
lowing cecal ligation and puncture [74]. Furthermore, the
preservation of immune responses in females was also asso-
ciated with higher survival rates following the induction of
sepsis [74]. Subsequently, further studies were conducted
investigating the effect of gender on cell-mediated immunity
following injury and blood loss. In particular, females in the
proestrus state showed enhanced IL-1 and IL-6 release by
splenic and peritoneal macrophages, and splenocyte IL-2 and
IL-3 release, as opposed to depressed macrophage and
splenocyte functions in males under such conditions [75].
Higher plasma estradiol and/or higher plasma prolactin levels
in proestrus females might contribute to the enhanced
immune responses following hemorrhage in proestrus
females. Furthermore, administration of estrogen to castrated
male mice that were supplemented with testosterone
improved the depressed immune responses in those animals
[76]. In addition, treatment of male mice with estradiol nor-
malized the depressed immune responses after trauma and
hemorrhage and improved the survival rate following subse-
quent sepsis [77]. Since estradiol replacement therapy is
associated with an increased rate of thromboembolism, this
therapy is not useful in surgical patients [78]. Such complica-
tions, however, have not been reported with regard to the
steroid hormone dehydroepiandrosterone, which has been
reported to display estrogenic effects [79]. Moreover, treat-
ment of male mice following trauma and blood loss prevented
immunosuppression [80]. Since dehydroepiandrosterone is
used clinically as a long-term immunoenhancing drug in
humans, this hormone might represent a useful therapy for
preventing immunodepression in surgical patients.
In addition to female sex steroids, the lower levels of male
hormones in female animals compared to males might also
contribute to the divergent immunoresponsiveness following
injury and blood loss. Support for the importance of male sex
hormones in producing the immune depression in males fol-
lowing hemorrhage comes from recent studies indicating that
castration of male mice two weeks prior to hemorrhage pre-
vented the depression of splenic and peritoneal
macrophages following the hemorrhagic insult [76,81]. More-
over, depletion of testosterone by castration prior to hemor-
rhage normalized the IL-6 release by Kupffer cells following
hemorrhage [76,81]. In attempting to address whether
testosterone per se is responsible for the depressed
macrophage functions following hemorrhage in males,
studies were conducted in which castrated male mice were
treated with 5α-dihydrotestosterone prior to trauma-hemor-
rhage [76]. The results demonstrated that castrated male
mice treated with testosterone (which had higher plasma
testosterone levels than intact males) displayed similar
immune responses to hemorrhage to those shown by intact
males, namely depression of splenic and peritoneal
macrophage function [76]. Similarly, treatment of female mice
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Figure 2
Hypothesis of the cascade of events following major surgery that lead
to the development of depressed immune responses and increased
susceptibility to sepsis. TGF-β, transforming growth factor β; TNF-α,
tumor necrosis factor α.with 5α-dihydrotestosterone also depressed splenic and peri-
toneal macrophage function as well as splenocyte responses
[25,82]. In addition, gender-specific immune responses have
also been demonstrated in the thymus, the primary location of
T cell lymphopoiesis [83]. The exact mechanism, however, for
the immunomodulatory properties of male and female sex
steroids following trauma-hemorrhage remains unknown.
Similar observations have been obtained in clinical trials fol-
lowing sepsis, surgery, or trauma and blood loss. In this
regard, Bone demonstrated, in a retrospective study incorpo-
rating four major sepsis studies, a preponderance of morbid-
ity and mortality in males compared to females [70].
McGowan et al. also reported a significantly higher incidence
of bacteremic infections in males than in females [72]. A
recent prospective study by Schröder et al. confirms that
gender differences were observed in human sepsis, with a
significantly better prognosis for women [73]. Hospital-mor-
tality rate in this study was 70% for male compared to 26%
for female patients following the induction of sepsis. Similarly,
following injury, male gender has been shown to be a risk
factor for the development of septic complications and pneu-
monia [84–86].
In summary the above studies suggest that gender, as well as
the state of the estrus cycle in females, should be taken into
consideration in designing not only experimental but also clin-
ical studies concerning immune responses following trauma
and shock. Moreover, the results of these studies suggest
that administration of sex steroids or treatment with their spe-
cific blockers should be considered as a novel and useful
approach for modulating the immune responses in those
patients.
Conclusion
The above studies indicate that injury, trauma, and blood loss
produce a marked suppression in cell-mediated immunity and
an increased susceptibility to subsequent sepsis and wound
infection. Furthermore, global as well as differential effects can
be observed on macrophages that are dependent on their
anatomical location. The use of a variety of immunomodulatory
agents (e.g. dilitiazem, chloroquine, ibuprofen, IFN-γ, prolactin,
metclopramide, and flutamide) have been shown to be helpful
for the normalization of the altered immune responses follow-
ing trauma and hemorrhage in experimental studies. The
success in the use of immunomodulatory agents following
hemorrhage in rodent models appears to be promising in the
development of new therapeutic concepts for the treatment of
immunosuppression and for decreasing the mortality from sub-
sequent sepsis in humans. However, careful evaluation of both
the benefits and potential adverse effects of therapy is needed
before widespread clinical use can be envisioned. Recently,
administration of G-CSF perioperatively has been shown to
prevent immunosuppression following major surgery. The
enhanced release of new, unaltered monocytes appears to be
responsible for the immunoenhancing effects of G-CSF.
Larger clinical trials should be initiated to verify that the
immunoprotective effects of G-CSF are associated with a
decreased susceptibility of surgical patients to infectious com-
plications, thereby decreasing the mortality rate.
The immunoinflammatory response, and subsequent sepsis,
is still one of the major causes of morbidity and mortality fol-
lowing major surgery. While significant advances have been
made, it is important to further define the pathophysiology
and identify the precise mechanisms responsible for the
depression of the cell-mediated immunity using experimental
animal models. However, these animal models should take
into consideration the various manipulations that the patient
receives as well as the effect of gender, nutritional status,
pre-existing conditions etc. Effective treatment regimes for
patients can only be developed when models of injury begin
to consider these factors.
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